Morgan Stanley 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 10:13 am Sale |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
MORGAN STANLEY MS |
515,050 5.100% |
-198,456 (-27.81%) |
Filing |
| 2023-02-08 2:48 pm Purchase |
2022-12-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
MORGAN STANLEY MS |
713,505 7.200% |
713,505 (New Position) |
Filing |